AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31639034 — intervention group
Group type: EXPERIMENTAL
Intervention: tofacitinib with methotrexate (MTX)
Number of subjects: 109
Study 31639034 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 109
Study 31639034 — intervention group
Group type: COMPARATOR
Intervention: Clinical Disease Activity Index (CDAI) and Disease Activity Score in 28 joints, erythrocyte sedimentation rate (DAS28-4[ESR])
Number of subjects: 109
Study 27868194 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (300 IU/kg/day, not to exceed 5,000 IU/day)
Number of subjects: 109
Study 27868194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 26714164 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab (4 mg kg(‐1) loading dose followed by 5 weekly 2 mg kg(‐1) doses)
Number of subjects: 79
Study 26714164 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Number of subjects: 79
Study 23749059 — intervention group
Group type: EXPERIMENTAL
Intervention: Inexpensive general-purpose LED headlight
Number of subjects: 0
Study 23749059 — intervention group
Group type: COMPARATOR
Intervention: Purpose-built surgical LED headlight
Number of subjects: 0
Study 22223196 — intervention group
Group type: EXPERIMENTAL
Intervention: Staff group (SG)
Number of subjects: 292
Study 22223196 — intervention group
Group type: COMPARATOR
Intervention: Peer-assisted learning group (PG)
Number of subjects: 292
Study 22223196 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall satisfaction with teaching environment
Number of subjects: 292
Study 22223196 — intervention group
Group type: COMPARATOR
Intervention: Peer-assisted learning system (PAL)
Number of subjects: 292
Study 20623180 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab treatment in HER2-positive patients
Number of subjects: 175
Study 20623180 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (NT)
Number of subjects: 175
Study 20623180 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-chemotherapy sHER2 levels
Number of subjects: 175
Study 20623180 — intervention group
Group type: EXPERIMENTAL
Intervention: sHER2 cut-off level of 10 ng/ml
Number of subjects: 175
Study 20623180 — intervention group
Group type: COMPARATOR
Intervention: sHER2 levels in HER2-negative patients
Number of subjects: 175
Study 17624687 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose diazepam (40 mg)
Number of subjects: 11
Study 17624687 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose opioid administration (150% normal dose)
Number of subjects: 11
Study 17624687 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg diazepam)
Number of subjects: 11
Study 15886441 — intervention group
Group type: EXPERIMENTAL
Intervention: ACWD (automatic detection of cardiac waves boundaries)
Number of subjects: 49
Study 15886441 — intervention group
Group type: EXPERIMENTAL
Intervention: ACWD
Number of subjects: 49
Study 16625983 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication (1-week omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg twice daily)
Number of subjects: 100
Study 16625983 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole group (1-week omeprazole 20 mg twice daily)
Number of subjects: 100
Study 16625983 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 100
Study 16625983 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole group
Number of subjects: 100
Study 11307252 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% NaOCl
Number of subjects: 20
Study 11307252 — intervention group
Group type: EXPERIMENTAL
Intervention: Anolyte neutral cathodic (ANC) (300 mg L‐1 of active chlorine)
Number of subjects: 20
Study 11307252 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of anolyte ANC and catholyte
Number of subjects: 20
Study 11307252 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 20
Study 11307252 — intervention group
Group type: COMPARATOR
Intervention: NaOCl
Number of subjects: 20
Study 11307252 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ANC and catholyte
Number of subjects: 20
Study 9122640 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced osmolarity oral rehydration salt (ORS) solution (sodium 67, potassium 20, chloride 66, citrate 7, glucose 89 mmol/l, osmolality 249 mOsmol/kg)
Number of subjects: 34
Study 9122640 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced osmolarity oral rehydration salt (ORS) solution
Number of subjects: 34
Study 9122640 — intervention group
Group type: COMPARATOR
Intervention: Control group (hyperosmolar WHO/UNICEF ORS)
Number of subjects: 34
Study 2060161 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam (TNX) 20 mg once a day
Number of subjects: 13
Study 2060161 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen (KPF) 100 mg twice a day
Number of subjects: 13
Study 2060161 — intervention group
Group type: COMPARATOR
Intervention: Both TNX and KPF groups
Number of subjects: 13
Study 6519170 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden (4 mg)
Number of subjects: 6
Study 6519170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30608419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided pulsed radiofrequency (UGPRF)
Number of subjects: 136
Study 30608419 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound-guided pulsed radiofrequency
Number of subjects: 136
Study 30062516 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow vital capacity maneuver
Number of subjects: 57
Study 30062516 — intervention group
Group type: COMPARATOR
Intervention: Deflation maneuver
Number of subjects: 57
Study 27412394 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncologists with higher EOL care score (median 7)
Number of subjects: 182
Study 27412394 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncologists with higher EOL care score
Number of subjects: 182
Study 24271261 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic food (1 × 10⁷ CFU Lactobacillus sporogenes and 0.04 g inulin HPX/g) consumed two times a day for 9 weeks
Number of subjects: 52
Study 24271261 — intervention group
Group type: COMPARATOR
Intervention: Control food consumed two times a day for 9 weeks
Number of subjects: 52
Study 23394513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine at 180 mg
Number of subjects: 111
Study 23394513 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine at fourfold dose
Number of subjects: 111
Study 23394513 — intervention group
Group type: COMPARATOR
Intervention: Control group (allergic rhinitis)
Number of subjects: 111
Study 19549211 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice therapy and omeprazole (20 mg bid)
Number of subjects: 32
Study 19549211 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 32
Study 18771886 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular revascularization and best medical treatment (group A)
Number of subjects: 33
Study 18771886 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment only (group B)
Number of subjects: 33
Study 15977693 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection (20 units)
Number of subjects: 50
Study 15977693 — intervention group
Group type: COMPARATOR
Intervention: Lateral internal sphincterotomy
Number of subjects: 50
Study 12644777 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire
Number of subjects: 78
Study 12644777 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedigree interview
Number of subjects: 78
Study 12644777 — intervention group
Group type: COMPARATOR
Intervention: Chart review
Number of subjects: 78
Study 10551919 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron 12.5 mg (group-D)
Number of subjects: 120
Study 10551919 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg (group-M)
Number of subjects: 120
Study 10551919 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group-P)
Number of subjects: 120
Study 8916058 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine premedication
Number of subjects: 18
Study 8916058 — intervention group
Group type: COMPARATOR
Intervention: No morphine
Number of subjects: 18
Study 1984988 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS)
Number of subjects: 52
Study 1984988 — intervention group
Group type: COMPARATOR
Intervention: Intermittent positive pressure breathing (IPPB)
Number of subjects: 52
Study 30913472 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Decision Aid (PDA)
Number of subjects: 96
Study 30913472 — intervention group
Group type: COMPARATOR
Intervention: Control condition (publicly available resources)
Number of subjects: 96
Study 30913472 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA in non-specialist setting
Number of subjects: 96
Study 30913472 — intervention group
Group type: COMPARATOR
Intervention: Control in non-specialist setting
Number of subjects: 96
Study 30913472 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA in specialist setting
Number of subjects: 96
Study 30913472 — intervention group
Group type: COMPARATOR
Intervention: Control in specialist setting
Number of subjects: 96
Study 28664342 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil therapy (3.6 g of EPA and DHA)
Number of subjects: 105
Study 28664342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 28664342 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil therapy
Number of subjects: 105
Study 26102298 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Telephone Self-Management Support (ATSM)
Number of subjects: 362
Study 26102298 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 362
Study 23496277 — intervention group
Group type: COMPARATOR
Intervention: Delivery at 37 weeks
Number of subjects: 69
Study 23496277 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery at 38 weeks
Number of subjects: 69
Study 21041485 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment in pregnancy (IPTp)
Number of subjects: 402
Study 21041485 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 402
Study 21041485 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental infection at delivery
Number of subjects: 402
Study 21041485 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched infections
Number of subjects: 402
Study 19412007 — intervention group
Group type: EXPERIMENTAL
Intervention: Oats
Number of subjects: 23
Study 19412007 — intervention group
Group type: COMPARATOR
Intervention: Gluten (wheat, rye, barley)
Number of subjects: 23
Study 19412007 — intervention group
Group type: EXPERIMENTAL
Intervention: Oats (after gluten exclusion)
Number of subjects: 23
Study 17242315 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 mug/d)
Number of subjects: 450
Study 17242315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 15491374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve (B. breve) supplement, 1.6 x 10(8) cells, twice a day, starting from several hours after birth (Group A)
Number of subjects: 0
Study 15491374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve (B. breve) supplement, 1.6 x 10(8) cells, twice a day, starting 24 hours after birth (Group B)
Number of subjects: 0
Study 15491374 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C), no supplement
Number of subjects: 0
Study 15491374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve (B. breve) supplement, Group A vs Group B
Number of subjects: 0
Study 15491374 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve (B. breve) supplement, Group A
Number of subjects: 0
Study 12575591 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Salvia Injection (CSI) added to conventional treatment
Number of subjects: 60
Study 12575591 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 60
Study 9595973 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-beta-1a (Avonex; Biogen)
Number of subjects: 0
Study 9595973 — intervention group
Group type: COMPARATOR
Intervention: IFN-beta-1b
Number of subjects: 0
Study 7887107 — intervention group
Group type: COMPARATOR
Intervention: HF group receiving high dose fentanyl (55 micrograms.kg‐1)
Number of subjects: 30
Study 7887107 — intervention group
Group type: EXPERIMENTAL
Intervention: HF+TEA group receiving high dose fentanyl (55 micrograms.kg‐1) + TEA with 10 ml bupivacain 5 mg.ml‐1, followed by 4 ml every hour
Number of subjects: 30
Study 7887107 — intervention group
Group type: EXPERIMENTAL
Intervention: LF+TEA group receiving low dose fentanyl (15 micrograms.kg‐1) + TEA
Number of subjects: 30
Study 2463559 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise tests at 50, 100, 150, or 200 W for 30 seconds
Number of subjects: 4
Study 31922424 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 0
Study 31922424 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 31477164 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education intervention (up to two groups per puskesmas, led by trained individuals with diabetes, sessions held monthly for 18 months)
Number of subjects: 534
Study 31477164 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education intervention
Number of subjects: 534
Study 28653674 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthotic therapeutic electrical stimulation (TES)
Number of subjects: 29
Study 28653674 — intervention group
Group type: COMPARATOR
Intervention: Conventional training alone (Control)
Number of subjects: 29
Study 25792638 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg daily) and bevacizumab (15 mg·kg(‐1) on day 1, every 3 weeks)
Number of subjects: 224
Study 25792638 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (80 mg·m(‐2) on day 1, every 3 weeks) and gemcitabine (1250 mg·m(‐2) on days 1 and 8, every 3 weeks) and bevacizumab (15 mg·kg(‐1) on day 1, every 3 weeks)
Number of subjects: 224
Study 24192471 — intervention group
Group type: EXPERIMENTAL
Intervention: First method of ILIH nerve block (needle inserted between outer 1/4 and inner 3/4 of a line connecting anterior‐superior iliac spine to umbilicus)
Number of subjects: 120
Study 24192471 — intervention group
Group type: EXPERIMENTAL
Intervention: Second method of ILIH nerve block (needle inserted 1 cm medial and 1 cm superior to anterior‐superior iliac spine)
Number of subjects: 120
Study 24192471 — intervention group
Group type: COMPARATOR
Intervention: Both methods of ILIH nerve block
Number of subjects: 120
Study 20658133 — intervention group
Group type: EXPERIMENTAL
Intervention: Grading system for scoring severity of MoM disease on MRI
Number of subjects: 59
Study 19840379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfasalazine (1.5, 3, 4.5, or 6 grams daily)
Number of subjects: 10
Study 16930141 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim (6 mg single dose on day 1 post-transplant)
Number of subjects: 37
Study 16930141 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim (5 microg/kg daily subcutaneous injections starting on day 5 post-transplant)
Number of subjects: 37
Study 16930141 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim
Number of subjects: 37
Study 16930141 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim
Number of subjects: 37
Study 15191542 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of benzophenone-3 (BP-3)
Number of subjects: 32
Study 15191542 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of octyl-methoxycinnamate (OMC)
Number of subjects: 32
Study 15191542 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 3-(4-methyl-benzylidene) camphor (4-MBC)
Number of subjects: 32
Study 15191542 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of sunscreens (BP-3, OMC, 4-MBC)
Number of subjects: 32
Study 11355124 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic interventions identified by ICU physicians as having been tested by RCTs
Number of subjects: 446
Study 11355124 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions believed to improve survival
Number of subjects: 446
Study 9443587 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine precursor (L-DOPA) - 4 mg/kg Sinemet
Number of subjects: 7
Study 9443587 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin antagonist (Ritanserin) - 0.3 mg/kg
Number of subjects: 7
Study 9443587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 8440859 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Training
Number of subjects: 200
Study 8440859 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Quan
Number of subjects: 200
Study 8440859 — intervention group
Group type: COMPARATOR
Intervention: Control Group (Discussion Topics)
Number of subjects: 200
Study 3449801 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial A (exercise at 40% Wmax for 3 h)
Number of subjects: 7
Study 3449801 — intervention group
Group type: COMPARATOR
Intervention: Trial B (rest for 3 h)
Number of subjects: 7
Study 31851017 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density fractional CO2 laser
Number of subjects: 25
Study 31851017 — intervention group
Group type: COMPARATOR
Intervention: Medium-density fractional CO2 laser
Number of subjects: 25
Study 31851017 — intervention group
Group type: COMPARATOR
Intervention: Low-density fractional CO2 laser
Number of subjects: 25
Study 31851017 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathological evaluation with high-density laser treatment
Number of subjects: 25
Study 30728003 — intervention group
Group type: EXPERIMENTAL
Intervention: ART+C (1 mg/kg corticosteroids)
Number of subjects: 38
Study 30728003 — intervention group
Group type: COMPARATOR
Intervention: ART Alone
Number of subjects: 38
Study 30728003 — intervention group
Group type: EXPERIMENTAL
Intervention: ART+C
Number of subjects: 38
Study 28034773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligasure™ vascular sealing system
Number of subjects: 80
Study 28034773 — intervention group
Group type: COMPARATOR
Intervention: Conventional method with silk suture ligation
Number of subjects: 80
Study 26437498 — intervention group
Group type: EXPERIMENTAL
Intervention: Anhydrous dentifrice containing 0.454% w/w stannous fluoride
Number of subjects: 119
Study 26437498 — intervention group
Group type: COMPARATOR
Intervention: Negative control dentifrice containing 1,000 ppm fluoride, as sodium monofluorophosphate
Number of subjects: 119
Study 23483343 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine infusion
Number of subjects: 33
Study 23483343 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 33
Study 21439042 — intervention group
Group type: EXPERIMENTAL
Intervention: Mums4Mums telephone support intervention delivered by trained peer-supporters over a period of four months.
Number of subjects: 0
Study 21439042 — intervention group
Group type: EXPERIMENTAL
Intervention: Mums4Mums telephone support intervention
Number of subjects: 0
Study 20073428 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-diabetic group
Number of subjects: 656
Study 20073428 — intervention group
Group type: COMPARATOR
Intervention: Normoglucemic group
Number of subjects: 656
Study 16359878 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 65
Study 16359878 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle/brachial index after exercise
Number of subjects: 65
Study 16359878 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRS
Number of subjects: 65
Study 15199363 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid mixture (AAM) 12 grams/day for 12 weeks
Number of subjects: 65
Study 15199363 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 65
Study 15199363 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid mixture (AAM)
Number of subjects: 65
Study 11521934 — intervention group
Group type: EXPERIMENTAL
Intervention: New method of manipulative reduction, immobilisation and fixation using a U‐shaped plaster with the elbow in extension.
Number of subjects: 95
Study 11521934 — intervention group
Group type: COMPARATOR
Intervention: Conventional method of reduction and immobilisation in a plaster slab with the elbow in flexion.
Number of subjects: 95
Study 9850268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative MMC (0.2 mg/ml for 3 min) with post-operative 5-FU (5 mg in 0.5 ml of balanced salt solution) and ocular massage (OM)
Number of subjects: 60
Study 9850268 — intervention group
Group type: COMPARATOR
Intervention: Standard trabeculectomy with post-operative 5-FU (5 mg in 0.5 ml of balanced salt solution) and ocular massage (OM)
Number of subjects: 60
Study 9850268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative MMC + post-operative 5-FU
Number of subjects: 60
Study 9850268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative MMC without post-operative 5-FU
Number of subjects: 60
Study 9850268 — intervention group
Group type: EXPERIMENTAL
Intervention: No intraoperative MMC + post-operative 5-FU
Number of subjects: 60
Study 9850268 — intervention group
Group type: EXPERIMENTAL
Intervention: Only trabeculectomy
Number of subjects: 60
Study 8124697 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% xylitol chewing gum
Number of subjects: 17
Study 8124697 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% xylitol + 35% sorbitol chewing gum
Number of subjects: 17
Study 8124697 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5% xylitol + 52.5% sorbitol chewing gum
Number of subjects: 17
Study 8124697 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% sorbitol chewing gum
Number of subjects: 17
Study 8124697 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sorbitol mouthrinse
Number of subjects: 17
Study 8124697 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sucrose mouthrinse
Number of subjects: 17
Study 2664728 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenomate 100 mg t.i.d. for 5 days
Number of subjects: 30
Study 2664728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 923067 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocainide (400-600 mg loading doses, maintenance doses every 12 hours)
Number of subjects: 12